Commentary
Open Access
Improving the regulation of medical cannabis in Canada to better serve pediatric patients
Richard J. Huntsman, Lauren E. Kelly, Jane Alcorn, Juan Pablo Appendino, Richard E. Bélanger, Bruce Crooks, Yaron Finkelstein, Andrea Gilpin, Evan Lewis, Catherine Litalien, Julia Jacobs, Charlotte Moore-Hepburn, Timothy Oberlander, S. Rod Rassekh, Alexander E. Repetski, Michael J. Rieder, Alan Shackelford, Hal Siden, Michael Szafron, Geert W. ‘t Jong and Régis Vaillancourt; for the Cannabinoid Research Initiative of Saskatchewan and the Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium
CMAJ October 18, 2021 193 (41) E1596-E1599; DOI: https://doi.org/10.1503/cmaj.202169
Richard J. Huntsman
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
MDLauren E. Kelly
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
PhDJane Alcorn
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
DVM PhDJuan Pablo Appendino
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
MDRichard E. Bélanger
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
MDBruce Crooks
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
MBChBYaron Finkelstein
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
MDAndrea Gilpin
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
PhD MBAEvan Lewis
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
MDCatherine Litalien
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
MDJulia Jacobs
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
MDCharlotte Moore-Hepburn
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
MDTimothy Oberlander
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
MDS. Rod Rassekh
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
MD MHScAlexander E. Repetski
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Michael J. Rieder
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
MD PhDAlan Shackelford
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
MDHal Siden
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
MD MHScMichael Szafron
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
PhDGeert W. ‘t Jong
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
MD PhDRégis Vaillancourt
Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
PharmDArticle Information
vol. 193 no. 41 E1596-E1599
PubMed
History
- Published online October 17, 2021.
Copyright & Usage
© 2021 CMA Joule Inc. or its licensors This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
Author Information
- Richard J. Huntsman, MD,
- Lauren E. Kelly, PhD,
- Jane Alcorn, DVM PhD,
- Juan Pablo Appendino, MD,
- Richard E. Bélanger, MD,
- Bruce Crooks, MBChB,
- Yaron Finkelstein, MD,
- Andrea Gilpin, PhD MBA,
- Evan Lewis, MD,
- Catherine Litalien, MD,
- Julia Jacobs, MD,
- Charlotte Moore-Hepburn, MD,
- Timothy Oberlander, MD,
- S. Rod Rassekh, MD MHSc,
- Alexander E. Repetski,
- Michael J. Rieder, MD PhD,
- Alan Shackelford, MD,
- Hal Siden, MD MHSc,
- Michael Szafron, PhD,
- Geert W. ‘t Jong, MD PhD,
- Régis Vaillancourt, PharmD
- for the Cannabinoid Research Initiative of Saskatchewan and the Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium
- Division of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children’s Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children’s Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, ‘t Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children’s Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology (‘t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children’s Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
- Correspondence to: Richard Huntsman, dr.huntsman{at}usask.ca
Statistics from Altmetric.com
In this issue
Article tools
Respond to this article
Improving the regulation of medical cannabis in Canada to better serve pediatric patients
Richard J. Huntsman, Lauren E. Kelly, Jane Alcorn, Juan Pablo Appendino, Richard E. Bélanger, Bruce Crooks, Yaron Finkelstein, Andrea Gilpin, Evan Lewis, Catherine Litalien, Julia Jacobs, Charlotte Moore-Hepburn, Timothy Oberlander, S. Rod Rassekh, Alexander E. Repetski, Michael J. Rieder, Alan Shackelford, Hal Siden, Michael Szafron, Geert W. ‘t Jong, Régis Vaillancourt
CMAJ Oct 2021, 193 (41) E1596-E1599; DOI: 10.1503/cmaj.202169
Improving the regulation of medical cannabis in Canada to better serve pediatric patients
Richard J. Huntsman, Lauren E. Kelly, Jane Alcorn, Juan Pablo Appendino, Richard E. Bélanger, Bruce Crooks, Yaron Finkelstein, Andrea Gilpin, Evan Lewis, Catherine Litalien, Julia Jacobs, Charlotte Moore-Hepburn, Timothy Oberlander, S. Rod Rassekh, Alexander E. Repetski, Michael J. Rieder, Alan Shackelford, Hal Siden, Michael Szafron, Geert W. ‘t Jong, Régis Vaillancourt
CMAJ Oct 2021, 193 (41) E1596-E1599; DOI: 10.1503/cmaj.202169
Jump to section
Related Articles
Cited By...
- No citing articles found.